In vitro evaluation of activities of azithromycin, erythromycin, and tetracycline against Chlamydia trachomatis and Chlamydia pneumoniae
about
In vitro and in vivo activities of azithromycin, a new azalide antibiotic, against chlamydiaEffects of azithromycin and rifampin on Chlamydia trachomatis infection in vitro.In vitro activities of several antimicrobial agents against recently isolated and genotyped Chlamydia trachomatis urogenital serovars D through K.Chlamydia trachomatis genitourinary infections: laboratory diagnosis and therapeutic aspects. Evaluation of in vitro and in vivo effectiveness of azithromycin.Commonly used antibacterial and antifungal agents for hospitalised paediatric patients: implications for therapy with an emphasis on clinical pharmacokinetics.Effects of two antibiotic regimens on course and persistence of experimental Chlamydia pneumoniae TWAR pneumonitis.Susceptibilities of Chlamydia trachomatis isolates causing uncomplicated female genital tract infections and pelvic inflammatory disease.In vitro activities of azithromycin, clarithromycin, erythromycin, and tetracycline against 13 strains of Chlamydia pneumoniaeIntracellular multiplication and toxic destruction of cultured macrophages by Capnocytophaga canimorsusIn vitro activity of azithromycin (CP-62,993) against Chlamydia trachomatis and Chlamydia pneumoniae.In vitro activities of azithromycin, clarithromycin, L-ofloxacin, and other antibiotics against Chlamydia pneumoniaeDifferences in 23S ribosomal RNA mutations between wild-type and mutant macrolide-resistant Chlamydia trachomatis isolates.Use and safety of azithromycin in neonates: a systematic reviewAzithromycin (zithromax).Application of DNA chip scanning technology for automatic detection of Chlamydia trachomatis and Chlamydia pneumoniae inclusions.Commonly prescribed β-lactam antibiotics induce C. trachomatis persistence/stress in culture at physiologically relevant concentrations.Deconstructing the Chlamydial Cell Wall.Mutations in 23S rRNA and ribosomal protein L4 account for resistance in Chlamydia trachomatis strains selected in vitro by macrolide passage.In vitro activity of garenoxacin against Chlamydia spp.An open, comparative pilot study of thiamphenicol glycinate hydrochloride vs clarithromycin in the treatment of acute lower respiratory tract infections due to Chlamydia pneumoniae.Susceptibility of Chlamydia pneumoniae to azithromycin and doxycycline: methodological aspects on the determination of minimal inhibitory and minimal bactericidal concentrations.Antimicrobial susceptibility and therapy of infections caused by Chlamydia pneumoniae.Treatment of atypical pneumonia with azithromycin: comparison of a 5-day and a 3-day course.
P2860
Q33760662-94AC09A4-2FE5-442B-9EF7-06A0F6C8928DQ33983273-96568837-36FB-4E1F-9FD2-B7D1F55B606DQ34309562-9415BD17-C95C-45FB-8F65-B4EEA82AA08CQ34316767-FD9FB442-4FB9-4E1A-BF0A-3CD40EC10CF7Q34437719-68E58AEA-9E9E-487B-A38B-93AA539CB46AQ35110637-B9133BB3-705B-4F40-8BF4-AF8D2D33EDDDQ35112604-F7A73EF8-22BD-4102-BD00-04B31CA8AE8EQ35121993-ECA40C97-F79B-4F65-86FC-CD674A2F5B3FQ35436759-BAE84E87-F138-4C8C-B8D0-1AA321B5A83EQ35818615-18B71758-F5E4-4BDA-BD07-86DB3D377FDAQ35885610-0C6971B9-705C-4FBB-99BD-2DC6C525BB4FQ35942887-270FF5DE-6F55-4CA9-A835-6C8879F3C57FQ36374133-0F97DE2C-758E-44FE-B885-0B18CCB8EDDFQ36625096-C378B454-2C63-4F6C-A63D-0BB83C29ED82Q37544269-EE9E84B6-E1C3-4365-94B5-714123718B1FQ37708278-205CB032-95CE-40FF-8EF6-2F1B19FA0420Q37835599-D2FA014F-5EF8-4128-9CBE-51A8614F648DQ37852692-350D174B-F537-4CEB-A4BA-6A1F2E7363BEQ37857513-D83EEABF-5158-4A03-806C-1587D21C2BD3Q37871587-98D1AD82-FE4E-4126-B8CB-5920D9E7325EQ37883672-92A0ED7E-5496-4B1F-88EE-E8CC9D39AD84Q37888465-58B0FAFC-5C91-45B4-96EA-A2AA8F4BAC2EQ40639997-4500281F-6BBA-41E4-8FB0-F6829D0DA76A
P2860
In vitro evaluation of activities of azithromycin, erythromycin, and tetracycline against Chlamydia trachomatis and Chlamydia pneumoniae
description
1992 nî lūn-bûn
@nan
1992年の論文
@ja
1992年論文
@yue
1992年論文
@zh-hant
1992年論文
@zh-hk
1992年論文
@zh-mo
1992年論文
@zh-tw
1992年论文
@wuu
1992年论文
@zh
1992年论文
@zh-cn
name
In vitro evaluation of activit ...... matis and Chlamydia pneumoniae
@ast
In vitro evaluation of activit ...... matis and Chlamydia pneumoniae
@en
type
label
In vitro evaluation of activit ...... matis and Chlamydia pneumoniae
@ast
In vitro evaluation of activit ...... matis and Chlamydia pneumoniae
@en
prefLabel
In vitro evaluation of activit ...... matis and Chlamydia pneumoniae
@ast
In vitro evaluation of activit ...... matis and Chlamydia pneumoniae
@en
P2093
P2860
P356
P1476
In vitro evaluation of activit ...... matis and Chlamydia pneumoniae
@en
P2093
P2860
P304
P356
10.1128/AAC.36.2.291
P407
P577
1992-02-01T00:00:00Z